Tom W.L. Groeneveld

Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes

Leendert A. Trouw, Tom W.L. Groeneveld, Marc A. Seelen et al. · Journal of Clinical Investigation · 2004 · 208 citations · Full text

Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes

Leendert A. Trouw, Tom W.L. Groeneveld, Marc A. Seelen et al. · Journal of Clinical Investigation · 2004 · 206 citations

Interactions of the Extracellular Matrix Proteoglycans Decorin and Biglycan with C1q and Collectins

Tom W.L. Groeneveld, Melinda Oroszlán, Rick T. Owens et al. · The Journal of Immunology · 2005 · 123 citations

Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia – Long-term results of trial ALL-REZ BFM P95/96

Cornelia Eckert, Arend von Stackelberg, Karl Seeger et al. · European Journal of Cancer · 2012 · 98 citations

Hematological Malignancy, Lymphoid Neoplasia, Intermediate Risk +12

Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia

Stefanie Groeneveld‐Krentz, Jana Hof, A Mendioroz et al. · Leukemia · 2012 · 87 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +7